Michael Erdmann

24PUBLICATIONS
118CO-AUTHORS
Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 07, 2026
S1 guideline sweat gland carcinoma.

|May 26, 2026
Management of Facial Immune Checkpoint Inhibitor-Induced Vitiligo with Topical Ruxolitinib: Quantitative Assessment Using a Semi-Automatic Tool.

|Jan 22, 2026
Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy.

Kristine E Mayer, Jessica C Hassel, Jannik Sambale

|Nov 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.

Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl

|Jul 18, 2025
Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics.

Lisa Cuba, Frank Dörje, Rafaela Kramer

|Jun 03, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.

Georg C Lodde, Jessica C Hassel, Imke von Wasielewski

Pageof 4

Frequent Collaborators

11 joint publications

Markus Vincent Heppt

11 joint publications

Carola Berking

5 joint publications

Bastian Schilling

5 joint publications

Dirk Schadendorf